Clinical Trial Update: The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating metastasis-directed radiotherapy for oligoprogressive metastatic castration-resistant prostate cancer, with recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Prostate Cancer (Adenocarcinoma), OligoProgressive Metastatic Disease | Phase 2 | Status: RECRUITING